Research and Markets(http://www.researchandmarkets.com/research/0249be/global_drug_elutin)
has announced the addition of the "Global
Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market
(2011 - 2016)" report to their offering.
The coronary stents market has witnessed patterns of increasing market
growth along with some declining phases in its course of span. The
introduction of drug-eluting stents (DES) in year 2000 marked a high
market growth phase of the market. In the early 2000, the coronary stent
market witnessed a spurt in growth. However, the year 2006 and 2007
experienced a steep decline in the market revenues, as a result of
release of some adverse clinical trials raising questions about safety
and efficacy of DES. The market again started regaining its growth phase
by 2008 with improvements in its stability. Prior to the introduction of
drug-eluting stents (DES), Bare metal stents (BMS) captured the largest
market share of Coronary Stent market worldwide. However, as a result of
high penetration rates of DES now, its market share is the highest
contributor to the market.
The global stent market in alignment to the high prevalence of
cardiovascular diseases is gaining in its market share year after year.
Also, owing the growth in demand for minimally invasive procedures,
these stents especially drug-eluting stents are finding rapid increase
in their market penetration of more than 60% approximately. Increase in
the elderly population, lifestyle changes leading to Obesity and advent
of advanced technologies such as bio absorbable and new generation
stents are few major driving factors for the Global coronary stent
market. Among the various market across the geographies, U.S forms the
largest market for the Coronary stents followed by Europe, Asia-Pacific
region countries, Japan and China. The leading players in this market
include Johnson & Johnson, Boston Scientific, Abbott Laboratories and
Medtronics forming the major share of the market worldwide.
The report covers all the major types of coronary stents - i.e. Drug
Eluting Stents, Bare Metal Stents and Bio-Absorbable Stents. The report
discusses the key influencing factors for the coronary stent market
across the geographies. The report also includes an in-depth analysis of
different sub-segments. The report estimates, forecasts the market sizes
(2010-2016) and growth rates for different segments and geographies.
The report analysis the global trend of coronary stent market and
discusses the rationale behind various industry moves. The report
provides competitive scenario of this market and highlights major market
going-on. An in-depth geographic analysis is conducted for each of the
sub-segment in the major regional markets of Americas, Europe, Asia and
ROW.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Understanding Of The Market
Chapter 3 Market Overview
Chapter 4 Market Segmentation
Chapter 5 Competitive Landscape
Chapter 6 Trend Analysis
Chapter 7 Clinical Trials
Chapter 8 Company Profiles
Companies Mentioned:
-
Boston Scientific
-
Johnson & Johnson
-
Abbott Laboratories
-
Medtronic, Inc.
-
Betriebskrankenkasse Der B. Braun Melsungen
-
Bioring Sa
-
Cornova
-
Balton Ltd.
For more information visit http://www.researchandmarkets.com/research/0249be/global_drug_elutin